Filter Results:
(4,328)
Show Results For
- All HBS Web
(4,328)
- People (16)
- News (1,517)
- Research (2,186)
- Events (3)
- Multimedia (132)
- Faculty Publications (1,542)
Show Results For
- All HBS Web
(4,328)
- People (16)
- News (1,517)
- Research (2,186)
- Events (3)
- Multimedia (132)
- Faculty Publications (1,542)
- September 2, 2020
- Article
How to Pay for Public Option Without Tax Hike
By: Regina E. Herzlinger and Richard Boxer
A bipartisan combination of the two parties’ most popular initiatives can expand health care coverage, significantly reduce costs, and enable freedom of choice, without raising taxes. Along the way, we can revitalize competition between public and private plans. Our... View Details
Keywords: Health Insurance; Public Option; Health Care and Treatment; Insurance; Cost Management; United States
Herzlinger, Regina E., and Richard Boxer. "How to Pay for Public Option Without Tax Hike." RealClearPolicy (September 2, 2020).
- April 2022
- Teaching Note
CVS Health: Prescription for Transformation
By: Rosabeth Moss Kanter and Catarina Martinez
In 2021, new CEO Karen Lynch (named the most powerful woman in business) considered the next transformation phase for CVS Health (a Fortune 5 corporate giant). The 2018 acquisition of Aetna insurance brought her to the company as part of its long evolution from a... View Details
- 29 Aug 2016
- News
Health Insurers’ Pullback Threatens to Create Monopolies
- 01 Dec 2011
- News
Research With Impact: Changing Global Health Practices
public policy, and social challenges. In health care, for example, the dominant policy model assumes that access and affordability are the keys to improving care for the poor. In Ashraf’s view, “We can’t... View Details
- March 2014 (Revised December 2014)
- Case
Vision 2020: Takeda and the Vaccine Business
By: John A. Quelch and Margaret L. Rodriguez
In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003... View Details
Keywords: Health Care; Global; NGO; Public Health; Japan; GSK; Vaccine; Supply Chain; Market Entry; Health; Health Care and Treatment; Trade; Market Entry and Exit; Global Strategy; Health Industry; Health Industry
Quelch, John A., and Margaret L. Rodriguez. "Vision 2020: Takeda and the Vaccine Business." Harvard Business School Case 514-084, March 2014. (Revised December 2014.)
- October 2013
- Case
FasterCures: Removing Barriers to Treatments
By: Richard G. Hamermesh and James Weber
In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details
Keywords: Health Care; Health Care Industry; Health Care Policy; Health Services; Healthcare; Healthcare Reform; Healthcare Ventures; Nonprofit; Non-profit Management; Not-for-profit; Incubator; Accelerator; Venture Philanthropy; Medical Services; Medical Solutions; Medical Research; Medical Treatment; Clinical Trials; Drug Reimbursement; Early Stage; Early Stage Research Funding; Early Stage Funding; Milken Institute; Michael Milken; David Baltimore; Partnering For Cures; National Institutes Of Health; Cancer Care In The U.S.; Cancer Care Services; Policy-making; Health Care and Treatment; Health; Health Testing and Trials; Entrepreneurship; Social Entrepreneurship; Nonprofit Organizations; Policy; Health Industry; United States; District of Columbia
Hamermesh, Richard G., and James Weber. "FasterCures: Removing Barriers to Treatments." Harvard Business School Case 814-003, October 2013.
- Web
Organize Care Around Medical Conditions - Institute For Strategy And Competitiveness
their ability to serve the complex and interrelated needs of each patient over the full cycle of care. The greatest improvements in health care... View Details
- 05 Sep 2013
- News
Who Will Radically Disrupt American Health Care?
- 2023
- Working Paper
Achieving Universal Health Insurance Coverage in the United States: Addressing Market Failures or Providing a Social Floor?
By: Katherine Baicker, Amitabh Chandra and Mark Shepard
The United States spends substantially more on health care than most developed countries, yet leaves a greater share of the population uninsured. We suggest that incremental insurance expansions focused on addressing market failures will propagate inefficiencies and... View Details
Baicker, Katherine, Amitabh Chandra, and Mark Shepard. "Achieving Universal Health Insurance Coverage in the United States: Addressing Market Failures or Providing a Social Floor?" NBER Working Paper Series, No. 30854, January 2023.
- July 2020
- Article
Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany
By: Victoria D. Lauenroth, Aaron S. Kesselheim, Ameet Sarpatwari and Ariel Dora Stern
Worldwide spending on prescription drugs has increased dramatically in recent years. Although this increase has been particularly pronounced in the U.S., it remains largely unaddressed there. In Europe, however, different approaches to regulating drug prices have been... View Details
Keywords: Pharmaceuticals; Prescription Drug Costs; Drug Pricing; Access To Care; Cost Reduction; Health Care and Treatment; Price; Governing Rules, Regulations, and Reforms; Cost Management; Germany
Lauenroth, Victoria D., Aaron S. Kesselheim, Ameet Sarpatwari, and Ariel Dora Stern. "Lessons from the Impact of Price Regulation on the Pricing of Anticancer Drugs in Germany." Health Affairs 39, no. 7 (July 2020): 1185–1193.
- April–June 2018
- Article
Establishing Teams: How Does It Change Practice Configuration, Size, and Composition?
By: Alyna Chien, Michael Anne Kyle, Antoinette S. Peters, Shalini Tendulkar, Molly Ryan, Karen Hacker and Sara J. Singer
Little is known about how practices reorganize when transitioning from traditional practice organization to team-based care. We compared practice-level (1) configuration as well as practice- and team-level (2) size and (3) composition, before and after establishing... View Details
Keywords: Academic Medicine; Primary Care; Team-based Care; Health Care and Treatment; Groups and Teams; Organizational Change and Adaptation
Chien, Alyna, Michael Anne Kyle, Antoinette S. Peters, Shalini Tendulkar, Molly Ryan, Karen Hacker, and Sara J. Singer. "Establishing Teams: How Does It Change Practice Configuration, Size, and Composition?" Journal of Ambulatory Care Management 41, no. 2 (April–June 2018): 146–155.
- September 17, 2020
- Article
Protecting Vulnerable Older Patients during the Pandemic
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
Older people (70 years and older) with multiple chronic conditions have the highest risk of being hospitalized and dying from COVID-19. The recent COVID-19 pandemic has highlighted how a strong primary care system can play an important role in protecting this group of... View Details
Keywords: COVID-19; High-risk Patients; Primary Care; Health Pandemics; Health Care and Treatment; Innovation and Invention; Demographics; Age
Ikram, Umar, Susanna Gallani, Jose F. Figueroa, and Thomas W. Feeley. "Protecting Vulnerable Older Patients during the Pandemic." NEJM Catalyst (September 17, 2020).
- 15 Dec 2024
- News
Agenda: Amanda E/J Morrison (MBA 2014)
women as an over-the-counter form of emergency contraception. But it was always a “Plan B” for a broken condom or a bad decision. The cofounder and CEO of Julie, Amanda E/J Morrison (MBA 2014), is rebranding... View Details
- February 2009 (Revised December 2009)
- Case
Merck: Global Health and Access to Medicines
By: V. Kasturi Rangan and Katharine Lee
The case describes the effort of Merck, a global leader in pharmaceuticals, in making available its medicines to the poor. The challenge for the company (or for that matter, any pharmaceutical company) is how to integrate its business strategy with its corporate social... View Details
Keywords: Globalized Firms and Management; Health Care and Treatment; Emerging Markets; Corporate Social Responsibility and Impact; Poverty; Business Strategy; Pharmaceutical Industry
Rangan, V. Kasturi, and Katharine Lee. "Merck: Global Health and Access to Medicines." Harvard Business School Case 509-048, February 2009. (Revised December 2009.)
- 03 Nov 2014
- News
A Recap of the U.S. News Hospital of Tomorrow Forum 2014
- Research Summary
Clinical Trials as a setting for Health Policy and Management Research
The clinical trial marketplace is in flux. A decade ago, pharmaceutical firms almost exclusively conducted the study of their novel drug compounds within major academic medical centers. But today, industry-sponsored clinical trials are increasingly using community... View Details
- Web
Health Business Fulltext Elite | Baker Library
Health Business Fulltext Elite Journal articles on all non-clinical aspects of health care management. Read More Includes aspects View Details
- Web
Mental Health Awareness Month | Baker Library
Markets > Market Maps Explore relevant Frost & Sullivan reports: The Future of Mental Health Management Emerging Digital Health Technology Innovations Transforming Mental View Details
- 24 Apr 2014
- News
Student turns family health crisis into online solution
When Shana Hoffman (MBA 2014) and her family tried to navigate the world of health care in the US to help Hoffman’s father with his medical issues, the electrical systems... View Details
- 20 Nov 2015
- News